Effects of silver nanoparticles on rat hepatic cytochrome P450 enzyme activity

References

• Alt V, Bechert T, Steinrücke P, Wagener M, Seidel P, Dingeldein E, Domann E, Schnettler R. (2004). An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 25:4383–4391.
   PubMed Web of Science ®Google Scholar
• Cha K, Hong HW, Choi YG, Lee MJ, Park JH, Chae HK, Ryu G, Myung H. (2008). Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. Biotechnol Lett 30:1893–1899.
   PubMed Web of Science ®Google Scholar
• Cho WS, Cho M, Jeong J, Choi M, Han BS, Shin HS, Hong J, Chung BH, Jeong J, Cho MH. (2010). Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 245:116–123.
   PubMed Web of Science ®Google Scholar
• Emoto C, Yamazaki H, Yamasaki S, Shimada N, Nakajima M, Yokoi T. (2000). Characterization of cytochrome P450 enzymes involved in drug oxidations in mouse intestinal microsomes. Xenobiotica 30:943–953.
   PubMed Web of Science ®Google Scholar
• Foldbjerg R, Dang DA, Autrup H. (2011). Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 85:743–750.
   PubMed Web of Science ®Google Scholar
• Fröhlich E, Kueznik T, Samberger C, Roblegg E, Wrighton C, Pieber TR. (2010). Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes. Toxicol Appl Pharmacol 242:326–332.
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ. (1996). The CYP2D subfamily. In: Ioannides C ed Cytochromes P450: Metabolic and Toxicological Aspects. Florida: CRC Press, 183–210.
   Google Scholar
• Greulich C, Kittler S, Epple M, Muhr G, Köller M. (2009). Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch Surg 394:495–502.
   PubMed Web of Science ®Google Scholar
• Guéguen Y, Souidi M, Baudelin C, Dudoignon N, Grison S, Dublineau I, Marquette C, Voisin P, Gourmelon P, Aigueperse J. (2006). Short-term hepatic effects of depleted uranium on xenobiotic and bile acid metabolizing cytochrome P450 enzymes in the rat. Arch Toxicol 80:187–195.
   PubMed Web of Science ®Google Scholar
• Huang SM, Strong JM, Zhang L, Reynolds KS, Nallani S, Temple R, Abraham S, Habet SA, Baweja RK, Burckart GJ, Chung S, Colangelo P, Frucht D, Green MD, Hepp P, Karnaukhova E, Ko HS, Lee JI, Marroum PJ, Norden JM, Qiu W, Rahman A, Sobel S, Stifano T, Thummel K, Wei XX, Yasuda S, Zheng JH, Zhao H, Lesko LJ. (2008). New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J Clin Pharmacol 48:662–670.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ. (2008). Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20:575–583.
   PubMed Web of Science ®Google Scholar
• Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, Chang HK, Lee JH, Oh KH, Kelman BJ, Hwang IK, Yu IJ. (2010). Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 7:20.
   PubMed Web of Science ®Google Scholar
• Koide CL, Collier AC, Berry MJ, Panee J. (2011). The effect of bamboo extract on hepatic biotransforming enzymes–findings from an obese-diabetic mouse model. J Ethnopharmacol 133:37–45.
   PubMed Web of Science ®Google Scholar
• Lamb JG, Hathaway LB, Munger MA, Raucy JL, Franklin MR. (2010). Nanosilver particle effects on drug metabolism in vitro. Drug Metab Dispos 38:2246–2251.
   PubMed Web of Science ®Google Scholar
• Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, Van Eijkeren JC, Geertsma RE, De Jong WH. (2010). The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31:8350–8361.
   PubMed Web of Science ®Google Scholar
• Lin JH, Lu AY. (1998). Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 35:361–390.
   PubMed Web of Science ®Google Scholar
• Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, Mortensen A, Lam HR, Larsen EH. (2011). Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18.
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis GM, de Kanter R. (2006). Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2:875–894.
   PubMed Web of Science ®Google Scholar
• Moiemen NS, Shale E, Drysdale KJ, Smith G, Wilson YT, Papini R. (2011). Acticoat dressings and major burns: systemic silver absorption. Burns 37:27–35.
   PubMed Web of Science ®Google Scholar
• Otyepka M, Skopalík J, Anzenbacherová E, Anzenbacher P. (2007). What common structural features and variations of mammalian P450s are known to date? Biochim Biophys Acta 1770:376–389.
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Mäenpää J, Taavitsainen P, Rautio A, Raunio H. (1998). Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28:1203–1253.
   PubMed Web of Science ®Google Scholar
• Rahman MF, Wang J, Patterson TA, Saini UT, Robinson BL, Newport GD, Murdock RC, Schlager JJ, Hussain SM, Ali SF. (2009). Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 187:15–21.
   PubMed Web of Science ®Google Scholar
• Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet JB. (2008). Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother 61:869–876.
   PubMed Web of Science ®Google Scholar
• Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Chang HK, Lee JH, Cho MH, Kelman BJ, Yu IJ. (2009). Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452–461.
   PubMed Web of Science ®Google Scholar
• Tang J, Xiong L, Wang S, Wang J, Liu L, Li J, Yuan F, Xi T. (2009). Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 9:4924–4932.
   PubMed Web of Science ®Google Scholar
• Williams PA, Cosme J, Ward A, Angove HC, Matak Vinkovic D, Jhoti H. (2003). Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 424:464–468.
   PubMed Web of Science ®Google Scholar
• Yuan R, Madani S, Wei XX, Reynolds K, Huang SM. (2002). Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metab Dispos 30:1311–1319.
   PubMed Web of Science ®Google Scholar
• Zhang QY, Dunbar D, Ostrowska A, Zeisloft S, Yang J, Kaminsky LS. (1999). Characterization of human small intestinal cytochromes P-450. Drug Metab Dispos 27:804–809.
   PubMed Web of Science ®Google Scholar